- Previous Close
174.56 - Open
173.09 - Bid 174.71 x 200
- Ask 175.06 x 100
- Day's Range
171.74 - 177.70 - 52 Week Range
111.20 - 187.12 - Volume
134,584 - Avg. Volume
156,223 - Market Cap (intraday)
6.282B - Beta (5Y Monthly) 1.28
- PE Ratio (TTM)
102.33 - EPS (TTM)
1.71 - Earnings Date Nov 5, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
181.00
Novanta Inc., together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. The Precision Medicine and Manufacturing segment offers photonics-based solutions, including laser scanning, beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. The Robotics and Automation segment offers optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles. The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is headquartered in Bedford, Massachusetts.
www.novanta.com2,900
Full Time Employees
December 31
Fiscal Year Ends
Sector
Scientific & Technical Instruments
Industry
Recent News: NOVT
View MorePerformance Overview: NOVT
Trailing total returns as of 10/9/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NOVT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NOVT
View MoreValuation Measures
Market Cap
6.28B
Enterprise Value
6.72B
Trailing P/E
101.73
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.02
Price/Book (mrq)
8.95
Enterprise Value/Revenue
7.47
Enterprise Value/EBITDA
40.19
Financial Highlights
Profitability and Income Statement
Profit Margin
6.91%
Return on Assets (ttm)
5.30%
Return on Equity (ttm)
9.36%
Revenue (ttm)
899.85M
Net Income Avi to Common (ttm)
62.16M
Diluted EPS (ttm)
1.71
Balance Sheet and Cash Flow
Total Cash (mrq)
98.47M
Total Debt/Equity (mrq)
76.53%
Levered Free Cash Flow (ttm)
114.96M
Research Analysis: NOVT
View MoreCompany Insights: NOVT
NOVT does not have Company Insights
Research Reports: NOVT
View MoreLowering target price to $183.00
NOVANTA INC has an Investment Rating of HOLD; a target price of $183.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetLowering target price to $184.00
NOVANTA INC has an Investment Rating of HOLD; a target price of $184.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetRaising target price to $186.00
NOVANTA INC has an Investment Rating of HOLD; a target price of $186.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetRaising target price to $180.00
NOVANTA INC has an Investment Rating of HOLD; a target price of $180.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target